Your browser doesn't support javascript.
loading
Hopes and Hurdles of Employing Mesenchymal Stromal Cells in the Treatment of Cardiac Fibrosis.
Neuber, Sebastian; Emmert, Maximilian Y; Nazari-Shafti, Timo Z.
Affiliation
  • Neuber S; Cardiosurgical Research Group, Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, 13353 Berlin, Germany.
  • Emmert MY; Translational Cardiovascular Regenerative Technologies Group, BIH Center for Regenerative Therapies, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
  • Nazari-Shafti TZ; Cardiosurgical Research Group, Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, 13353 Berlin, Germany.
Int J Mol Sci ; 22(23)2021 Nov 30.
Article in En | MEDLINE | ID: mdl-34884805
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrosis / Mesenchymal Stem Cell Transplantation / Cell- and Tissue-Based Therapy / Heart Diseases Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2021 Document type: Article Affiliation country: Germany Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrosis / Mesenchymal Stem Cell Transplantation / Cell- and Tissue-Based Therapy / Heart Diseases Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2021 Document type: Article Affiliation country: Germany Country of publication: Switzerland